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Abstract 
 
Objective (s)  
Porin is  a  mitochondrial outer  membrane  channel, which usually functions as the pathway for the 
movement of various substances in and out of the mitochondria and is considered to be a component of 
the permeability transition (PT) pore complex that plays a role in the PT. We addressed the hypothesis that 
porin interacts with other mitochondrial proteins after ischemic injury. 
Materials and Methods 
For this purpose, we used in vivo 4-vessel occlusion model of rat brain and porin purification method by 
hydroxyapatite column. After SDS gel electrophoresis and silver nitrate staining, Western blotting was done 
for porin, adenine nucleotide translocase and cyclophilin-D proteins. 
Results  
Porin was purified from mitochondrial  mixture in ischemic brain and control groups. Investigation  of 
interaction of adenine nucleotide transposes (ANT) and cyclophilin-D with porin by Western blotting 
showed no proteins co-purified with porin from injured tissues. 
Conclusion  
The present study implies that there may not be interaction between porin, and ANT or cyclophilin-D, and 
if there is any, it is not maintained during the purification procedure. 
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Introduction 
Mitochondria play a crucial role in cell death. 
These organelles can play a critical role in the 
progression of necrotic cell death by activation 
of  phospholipases,  nucleases and proteases     
(1, 2), and apoptotic cell death by releasing 
proapoptotic  proteins,  such as cytochorome 
C,  apoptosis-inducing  factor  (AIF),  and 
Diablo-SMAC  from  the intermembrane space 
into the cytosol in response to a number of 
death-promoting  stimuli (3-5). The 
mitochondrial permeability transition pore 
(MPTP) is a nonspecific pore, permeable  to  
all  molecules  of  less  than  1.5  kDa,  and  
opens  under circumstances of excessive load 
of calcium (6). In ischemia/reperfusion, the 
MPTP has been identified as a  major 
participant in the mitochondrial pathways of 
cell death (6-11). During ischemia a 
decreasing in intracellular pH prevents MPTP 
opening (12). However, in the reperfusion 
phase there is a rapid increase of reactive 
oxygen species (ROS) formation and the pH 
returns to normal level, exciting MPTP 
opening and hence cell death (1). 
The molecular identity of the mitochondrial 
permeability transition pore has not  been 
established and its structure is controversial. 
The MPTP is assumed to be due to  the 
formation of dynamic multiprotein complexes 
at outer mitochondrial membrane (OMM) and 
inner mitochondrial membrane (IMM) 
contact sites (13). Biochemical and 
pharmacological evidence show that porin or 
voltage-dependent anion channel (VDAC) in 
the OMM is a component of  the 
mitochondrial permeability transition pore 
(14). During  ischemia/reperfusion this protein 
is directly involved in mitochondrial 
dysfunction, neuronal impairment, apoptosis 
and  necrosis (15, 16) and thereby could be a 
therapeutic target to prevent cellular 
degeneration (15). 
Adenine nucleotide translocase (ANT) in 
IMM is other presumptive component of 
MPTP and is thought to play a dual role in the 
transport of ADP and ATP across the 
mitochondrial inner membrane and an 
important mediator of apoptosis (17, 18). It is 
likely that the Ca
2+  requirement for the 
induction of the mitochondrial permeability 
transition pore opening  might  be  due  to        
the Ca
2+  dependent interaction between 
cyclophilin-D (CyP-D) resident in the 
mitochondrial matrix space and ANT in inner 
mitochondrial membrane (19).  Different 
investigations have shown that CyP-D can 
bind tightly to a VDAC/ANT complex and are 
constituents of the MPTP (20-24). In spite of 
these studies, VDAC and ANT-  knockout 
mice studies has shown that the VDAC and 
ANT are non-essential components of the 
MPTP  that  may  be dispensable for MPTP-
associated cell death (25, 26). However, the 
molecular identity of the MPTP has remained 
uncertain. 
In this study, we have isolated porin from an 
outer membrane of mitochondria by 
hydroxyapatite/celit chromatography. In 
order to confirm porin binding with ANT and 
cyclophilin-D after brain ischemia  and 
reperfusion, porin was purified  from 
mitochondrial proteins  and then its  binding 
with ANT and cyclophilin-D was confirmed 
by immunoblotting. 
 
Materials and Methods 
Rat brains mitochondria were prepared from 
male Wistar rats 18-30- days- old.  Animal 
care and handling was performed in 
accordance with the rules approved by the 
local research council at University of 
Toronto, Canada. 
 
Animal model 
Surgery was done in two groups: ischemic 
and sham groups. Transient brain ischemia 
was produced using the in vivo 4-vessel 
occlusion model (27). Briefly, in this method 
on the first day the experiment animals were 
anaesthetized with halothane 2.0% and 70% 
nitrous oxide (N2O) in oxygen (O2),  placed        
on a stereotaxic frame and the vertebral 
arteries were eletrocoagulated through the alar 
foraminae  of the first cervical vertebrae. On 
the following day, a temporary occlusion was 
produced by clamping of both common carotid 
arteries  for  30  min  and  so  completing                 
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the 4-vessel occlusion (carotid+vertebral). 
Animals that did not lose the righting reflex or 
convulsed during the ischemic insult were 
excluded from the experiments. Reperfusion 
was introduced by re-infusing the shed blood 
and by releasing the clamps placed around the 
carotid arteries. Animals were sacrificed after 
60 min of reperfusion and the brain was 
removed. Sham-operated rats were treated the 
same as controls.  
 
Porin purification 
Rat brain mitochondria were prepared from 
Wistar rats 18-30 olds, as described by De 
Pinto et al (28) and Perez Velazquez et al (15). 
Brain tissue was homogenized    in 0.25 M 
sucrose solution, containing 10 mM  Tris-
HCL, 0.5 Na EDTA, pH 7.4, and centrifuged 
at 2000 g for 3 min. Supernatants were 
separated and centrifuged at  12,500  g  for        
8 min, and the pellet resuspended in a solution 
containing 3% Ficoll, 0.12M mannitol, 0.03 M 
sucrose, 25 µM Na EDTA, pH 7.4. The 
solution  containing  the  resuspended  pellet  
was  layered  on  to  a  similar  volume  of  a 
solution containing 6% Ficoll, 0.24 M 
mannitol, 0.06 M sucrose and 50 µM Na 
EDTA and centrifuged at 11,500 g for 30 min. 
The mitochondrial pellets were then resuspended 
in the initial solution and centrifuged at 12,500 g 
for 10 min. All procedures were carried out at      
4 °C. The protease inhibitors leupeptin (1 mM), 
phenylmethyl-sulfonyl  fluoride  (PMSF,           
0.23 mM) and pepestatin were added to all 
solutions. Mitochondrial proteins  were then 
extracted from isolated mitochondria using a 
solubilization buffer containing  3%  Triton       
X-100, Tris–HCl, EDTA into 
hydroxyapatite/celite column. Protein collections 
were analyzed by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis. Developing 
of   gel   was   done   by   silver   nitrate   kit   
(Amersham Biosciences). Briefly at first the gel 
was fixed with fixing solution (ethanol and 
glacial acetic acid) for 30 min. After washing, 
sensitizing solution (ethanol, glutardialdehyde, 
sodium thiosulphate,  and sodium acetate) was 
added for 30 min and after  washing, silver 
solution  was added for  20  min  and  was 
developed  with  developing solution (sodium 
carbonate and formaldehyde). The purification 
process and silver nitrate staining were 
repeated three times. 
 
lmmunoblotting  
The proteins in mitochondria and cytosol were 
separated by 10% SDS-PAGE and were 
electrophoretically  transferred to PVDF 
membranes (Bio-Rad). Membrane was probed 
with the indicated antibodies at 4 ºC overnight. 
The primary antibodies were either a 1:10000 
dilution of rabbit VDAC1 [VDAC1 (N-18), 
USA], ANT (University of  Bristol, UK), and 
cyclophilin-D (abcam, USA). Detections were 
carried out by alkaline-phosphatase conjugated 
goat anti-mouse IgG (1:3000) (Promega, 
Madison, USA) and processed using the protoblot 
II  alkaline-  phosphatase system (Promega, 
Madison, USA). The immunoblotting study was 
repeated three times. 
                  
Results 
There is particularly strong evidence that porin is 
one of component of the PT  pore (9, 14). 
Accordingly, a porin purification was done for 
the identification of porin  binding proteins as 
candidate constituents of the pore. 
We examined mitochondrial porin at protein 
levels in normal and ischemic brains. In order to 
identify mitochondrial porin, a Triton X-100 
extract of mitochondrial  protein  was  subjected        
to chromatography on a hydroxyapatite/celite 
column.  As  shown  in  Figures  1  and  2,               
porin immunoreactivity was evident as a single 
30 kDa band detected by  Western  blot          
analysis.  The  mitochondrial  porin was   
successfully overexpressed in sham control group 
mitochondrial proteins fraction (second fraction) 
(Figure 1). In the ischemia group, porin specific 
band was observed with a polyclonal anti-porin 
antibody in second fraction of porin purification 
process (Figure 2).  
In order to study the interactions of porin with 
ANT and cyclophilin-D, we used Anti–ANT and 
Anti cyclophilin-D for total mitochondrial 
proteins, first and second  fractions after the 
chromatography.  ANT was strongly expressed 
in the mitochondrial proteins mixture             
and can  be  seen  that  a  single  30                 
kDa band was recognized  in Western blots of  
Mohammad Ali Atlasi et al 
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Figure 1. Silver staining (left) and Western blotting (right) of mitochondrial  proteins from rat brain of sham 
group. Lanes A and F are rainbow marker. Lanes B and C are first  fraction of mitochondrial proteins after 
chromatography. Lanes D, G, and H are second fraction of mitochondrial proteins after chromatography. Arrow show 
porin  purification  after second fraction. Lanes E and I are mitochondrial proteins mixture. Anti ANT has 
recognized ANT protein in mitochondrial proteins mixture (lane I) in level of 30 kDa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The anti-peptide polyclonal anti-porin antibody has recognized porin (left) and anti ANT has recognized ANT 
protein in Western blots after brain ischemia. Lane A is rainbow marker, lanes B, D, and F are second fraction of 
mitochondrial proteins after chromatography. Lane C is first fraction of mitochondrial proteins after chromatography. 
Lane E and G are mitochondrial protein mixture. Arrow shows ANT in level of 30 kDa in mixture of mitochondrial 
protein. After porin purification interaction porin and ANT did not occur (lane F). 
 
total mitochondrial  proteins in sham control 
group (Figure 3, lane C).   It was not 
expressed in the mitochondrial protein mixture 
after ischemia/reperfusion (Figure 2). Western 
blotting showed that cyclophilin-D was 
expressed  in mixture of mitochondrial 
proteins in ischemic brains (Figure 4, lane G) 
and virtually no band was seen in first and 
second fractions of the mitochondrial proteins 
in ischemic brain (Figure 4, lane E and F). 
These data did not reveal  ANT and 
cyclophilin-D proteins contemporary with 
porin in second fraction of porin purification 
process and so no interactions have occurred 
between these proteins in either control and 
ischemic brain. 
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Figure 3. Silver staining (left) and Western blotting (right) of mitochondrial    proteins from normal rat brain. Lane 
B is rainbow marker, lane A is second fraction of mitochondrial protein after chromatography. Porin purification is 
seen in the  level  of 30 kDa. Lane C is mixture of mitochondrial protein. Anti-ANT has recognized ANT protein 
(Arrow), and is not seen in the second fraction.  
 
 
 
Figure 4. Silver staining (left) and Western blotting (right) of mitochondrial  proteins from rat brain. Lanes  A  and  
B  are  second  fraction  of  mitochondrial  proteins  from ischemic  rat  brain  and  lane  C  is  second  fraction  of  
sham  operated  brain.  Porin purification is  seen in the level of 30 kDa. Lane D is rainbow marker. Anti 
cyclophilin-D has recognized cyclophilin-D protein in mitochondrial protein mixture of ischemic rat brain (lane G, 
arrow) and lanes E and F are the first and second fractions of mitochondrial proteins from ischemic rat brain. Anti 
cyclophilin-D has not recognized cyclophilin-D in either  fraction.  After  porin  purification interaction of porin  and 
cyclophilin-D did not occur (lane F).  
 
 
 
Discussion 
In this study, we have evaluated porin 
purification from mitochondria of rat brain 
by hydroxyapatite/celit chromatography after 
in vivo ischemic/reperfusion, and its analysis 
by Western blotting to define interaction of 
porin with ANT and cyclophilin-D. Attention 
has been paid to porin because of some studies 
suggesting its critical role in MPTP structure 
(9, 14, 16, 20, 29). 
In the present study, porin was purified 
according to the method of de Pinto by 
hydroxyapatite/celite chromatography. Porin 
solubilization with respect to total 
mitochondrial membrane protein is more 
efficient with the more hydrophobic detergents  
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such as Triton (30). Detergent in our study 
was Triton X-100 and porin purification was 
done efficiently. 
Our study did not show binding of porin 
with ANT and cyclophilin-D in the first or 
second soluble fractions; however Western blot 
technique confirmed existence of these proteins 
in the mitochondrial mixture. These data do not 
demonstrate the notion of a functional complex 
between these components. There are various 
evidence that VDAC, ANT and CyP-D are 
constituents of the PT pore. Studies using anti-
VDAC antibodies have provided experimental 
evidence for a direct role of the VDAC in the 
MPTP (31). Perez Velazquez et al.  showed           
that porin is  a crucial protein involved in 
mitochondrial and cell dysfunction, and it              
is  conceivable  that antibodies can be used              
as therapeutic agents (29).  Under 
ischemic/reperfusion of high matrix Ca2+and/or 
oxidative stress (2) porin interacts with ANT 
from IMM and cyclophilin-D from 
mitochondrial matrix and form MPTP (9-11, 13, 
20). It is thought that these proteins may be 
cross-linked through protein-protein interaction 
by formation of disulfide bridges (32). 
More direct evidence show that the ANT might 
bind CyP-D were provided through the use of          
a CyP-D affinity column (glutathione                         
S-transferase (GST) pull-down assays) (6). The 
role of Cyp-D in regulating the MPT is based on 
the observation that cyclosporin A  (CsA), a 
specific inhibitor of the cyclophilin family, 
blocks the MPT. ‘Pulldown’ experiments have 
revealed that cyclophilin-D binds specifically 
and tightly to a VDAC/ANT  complex and it 
does so even in the presence of cyclosporin A 
(20).  Reconstitutions  of Ca2+activated, CSA-
inhibited PT pore activity from purified ANT, 
VDAC and CyP-D in liposomes (20, 33) and   
black  lipid  membranes (34) have  confirmed  
that  these components  form  the  PT  pore  and  
binding  of  the  voltage  dependent  anion   
channel  (VDAC)  to  ANT  and  CyP-D. 
However, our research similar to some other 
studies (21, 35, 36) have suspected this 
hypothesis. Differences between these studies 
may reflect the different detergent solubilisation 
routine  and  kind of mitochondria. Woodfield     
et al (21) and present study used Triton X-100 
and liver mitochondria and brain mitochondria 
respectively rather than the heart mitochondria 
and  chaps detergent for solubilisation used by 
Crompton  et  al ( 20). Today there is some 
evidence that ANT is not normally the major 
pore  forming  component of the MPTP, but 
rather plays only a regulatory role (2). Whether 
ANT has an  obligatory pore-forming role has 
been questioned (19). Cyclophilin-D  facilitates 
the pore formation by its the peptidyl–prolyl cis–
trans isomerase activity (6) and probably is 
mitochondrial permeablization modulating and   
defending (37). Recently Baines et al has shown 
that mitochondria lacking all isoforms of porin 
exhibit normal pore  opening and are still 
sensitive to ischemia/reperfusion (25). 
Furthermore genetic studies have shown that 
mitochondria lacking VDAC1 still exhibited a 
normal cyclosporine-sensitive MPTP response 
(38).These evidence shows that probably porin is 
not an essential component of the MPTP.  
Our study does not suggest co-purification 
porin with ANT and cyclophilin-D.  Probably 
after ischemia/reperfusion interaction between 
these proteins does not occur or porin 
purification procedure separates contact sites 
between these proteins. It seems that more 
documents is needed for determination of MPTP 
structure. Recently Halestrap proposed that 
MPTP is enhanced by an interaction of the 
mitochondrial phosphate carrier (PiC), a ~30 
kDa inner mitochondrial membrane protein, with 
the “c” conformation of the ANT (36). However, 
more evidence is needed to prove this model. 
 
Conclusion 
Considering our findings in the present study, we 
can conclude that there may not be  interaction 
between porin and ANT or cyclophilin-D 
following brain ischemia/reperfuion, or if there is 
any, it is not maintained during the purification 
procedure.  
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